516 related articles for article (PubMed ID: 32899957)
1. The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers.
Argentati C; Tortorella I; Bazzucchi M; Emiliani C; Morena F; Martino S
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32899957
[TBL] [Abstract][Full Text] [Related]
2. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
[TBL] [Abstract][Full Text] [Related]
3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
4. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
Bi D; Wen L; Wu Z; Shen Y
Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
[TBL] [Abstract][Full Text] [Related]
5. The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.
Shinohara M; Sato N
Adv Exp Med Biol; 2019; 1128():85-101. PubMed ID: 31062326
[TBL] [Abstract][Full Text] [Related]
6. From attention-deficit hyperactivity disorder to sporadic Alzheimer's disease-Wnt/mTOR pathways hypothesis.
Grünblatt E; Homolak J; Babic Perhoc A; Davor V; Knezovic A; Osmanovic Barilar J; Riederer P; Walitza S; Tackenberg C; Salkovic-Petrisic M
Front Neurosci; 2023; 17():1104985. PubMed ID: 36875654
[TBL] [Abstract][Full Text] [Related]
7. A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers.
Marizzoni M; Mirabelli P; Mombelli E; Coppola L; Festari C; Lopizzo N; Luongo D; Mazzelli M; Naviglio D; Blouin JL; Abramowicz M; Salvatore M; Pievani M; Cattaneo A; Frisoni GB
Alzheimers Res Ther; 2023 May; 15(1):101. PubMed ID: 37254223
[TBL] [Abstract][Full Text] [Related]
8. Risk and protective factors for sporadic Alzheimer's disease.
Stozická Z; Zilka N; Novák M
Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis review: Alzheimer's overture guidelines.
Ferrer I
Brain Pathol; 2023 Jan; 33(1):e13122. PubMed ID: 36223647
[TBL] [Abstract][Full Text] [Related]
10. Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.
Islam S; Sun Y; Gao Y; Nakamura T; Noorani AA; Li T; Wong PC; Kimura N; Matsubara E; Kasuga K; Ikeuchi T; Tomita T; Zou K; Michikawa M
J Neurosci; 2022 Feb; 42(8):1574-1586. PubMed ID: 34987110
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.
Šimić G; Španić E; Langer Horvat L; Hof PR
Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331
[TBL] [Abstract][Full Text] [Related]
12. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease.
De Felice FG; Lourenco MV
Front Aging Neurosci; 2015; 7():94. PubMed ID: 26042036
[TBL] [Abstract][Full Text] [Related]
13. Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance.
Ayton S; Portbury S; Kalinowski P; Agarwal P; Diouf I; Schneider JA; Morris MC; Bush AI
Alzheimers Dement; 2021 Jul; 17(7):1244-1256. PubMed ID: 33491917
[TBL] [Abstract][Full Text] [Related]
14. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
15. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
16. Genetic associations of in vivo pathology influence Alzheimer's disease susceptibility.
Seo J; Byun MS; Yi D; Lee JH; Jeon SY; Shin SA; Kim YK; Kang KM; Sohn CH; Jung G; Park JC; Han SH; Byun J; Mook-Jung I; Lee DY; Choi M;
Alzheimers Res Ther; 2020 Nov; 12(1):156. PubMed ID: 33213512
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
18. The involvement of lipids in Alzheimer's disease.
Lim WL; Martins IJ; Martins RN
J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
[TBL] [Abstract][Full Text] [Related]
19. Differential Profile of Systemic Extracellular Vesicles From Sporadic and Familial Alzheimer's Disease Leads to Neuroglial and Endothelial Cell Degeneration.
Villar-Vesga J; Henao-Restrepo J; Voshart DC; Aguillon D; Villegas A; Castaño D; Arias-Londoño JD; Zuhorn IS; Ribovski L; Barazzuol L; Cardona-Gómez GP; Posada-Duque R
Front Aging Neurosci; 2020; 12():587989. PubMed ID: 33281599
[TBL] [Abstract][Full Text] [Related]
20. Special Issue: Alzheimer's disease.
Nguyen KV
AIMS Neurosci; 2018; 5(1):74-80. PubMed ID: 32341952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
